Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected Scott Willis·February 11, 2019Based on Aurora's results, investors may have to wait until 2020 for cannabis stocks to generate any earnings...Marijuana Analysis·2 Comments·
Significant Value Remains in Aphria: The Upside vs. Cannabis Peers Thomas George·February 4, 2019We look at the upside remaining for Aphria shares on a relative value basis and as a very...Marijuana Analysis·1 Comment·
Are the Best Returns in the Past for Marijuana Stocks? A Capital Markets Analysis Scott Willis·January 31, 2019An important report answering whether marijuana capital markets have gotten ahead of fundamentals. Is there upside left in pot stocks as a whole?Marijuana Analysis·6 Comments·
Tilray’s Stock Pledge Looking Like an Empty Promise Scott Willis·January 28, 2019If the CEO of Tilray is selling personal shares only weeks after his Private Equity firm committed to...Marijuana Analysis·1 Comment·
Green Growth’s Formal Aphria Offer is Lacking – Highlights Valuation Disconnect Scott Willis·January 23, 2019The Green Growth Offer Significantly Undervalues Aphria. Investors should feel comfortable owning the company as a standalone future cash flow machine.Marijuana Analysis·8 Comments·
U.S. Marijuana Scorecard (Winter 2019) Scott Willis·January 14, 2019A guide for investing in the public marijuana stocks of U.S. cannabis operators. Filled with the most useful...Marijuana Analysis·5 Comments·
Aphria Q2 2019 Earnings Review – Management Cloud Lifted, Assets Free to Shine Scott Willis·January 11, 2019With management stepping down and the short seller moving on, Aphria is once again an attractive target for...Marijuana Analysis·0 Comments·
Aphria – Let the Bidding Begin Scott Willis·December 28, 2018The hostile bid for Aphria has put consumer goods companies on notice. Invest now or lose out on...Marijuana Analysis·2 Comments·
Cronos – No Cash, No Deal….. Tough Times Scott Willis·December 6, 2018Cronos is running low on cash and without an Altria deal in sight, the company need to break-even...Marijuana Analysis·4 Comments·